Pluristem Therapeutics Inc. (PSTI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pluristem Therapeutics In...

    NASDAQ: PSTI · Real-Time Price · USD
    1.00
    -0.03 (-2.91%)
    At close: Jul 26, 2022, 6:00 AM

    Pluristem Therapeutics Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2021
    Revenue
    		 1.34M n/a
    Cost of Revenue
    		 682K n/a
    Gross Profit
    		 654K n/a
    Operating Income
    		 -23.33M -50.62M
    Interest Income
    		 n/a 492K
    Pretax Income
    		 -23.25M -49.87M
    Net Income
    		 -23.25M -49.87M
    Selling & General & Admin
    		 9.98M 20.56M
    Research & Development
    		 14M 30.07M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 23.98M 50.62M
    Interest Expense
    		 -873K 78K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 24.66M 50.62M
    Income Tax Expense
    		 n/a n/a
    Shares Outstanding (Basic)
    		 63.37M 28.11M
    Shares Outstanding (Diluted)
    		 63.37M 28.11M
    EPS (Basic)
    		 -3.56 -1.77
    EPS (Diluted)
    		 -3.56 -1.77
    EBITDA
    		 -23.33M -48.42M
    EBIT
    		 n/a -49.79M
    Depreciation & Amortization
    		 n/a 1.37M

    Add to Watchlist